Legal & General Group PLC Intra Cellular Therapies, Inc. Transaction History
Legal & General Group PLC
- $470 Billion
- Q3 2024
A detailed history of Legal & General Group PLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 157,842 shares of ITCI stock, worth $13.4 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
157,842
Previous 157,842
-0.0%
Holding current value
$13.4 Million
Previous $11.5 Million
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding ITCI
# of Institutions
378Shares Held
84.7MCall Options Held
319KPut Options Held
143K-
Vanguard Group Inc Valley Forge, PA9.63MShares$818 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$537 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY5.29MShares$449 Million0.03% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.85MShares$327 Million1.4% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.05MShares$259 Million3.36% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $8.02B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...